Kidney International

Article	Citations
Journal Club	1385
Function follows form: the quest for the best prognostic imaging biomarker in ADPKD	1360
Editorial Board	711
A pig kidney supporting human physiology	573
Subscription Information	354
In this issue	344
Editorial Board	234
Editorial Board	198
Challenges in the development of novel methodologies for measuring glomerular filtration rate	181
Gene editing: a near future for the treatment of genetic kidney diseases	171
In This Issue	160
Table of Contents	152
Subscription Information	138
Taking the A(llorecognition) train: connecting passenger T cells to DSA	134
Endothelial but not systemic ferroptosis inhibition protects from antineutrophil cytoplasmic antibody–induced crescentic glomerulonephritis	133
in this issue	124
Thirsty encounters of the third kind	119
Misuse of the Cox proportional hazards model and alternative approaches in kidney outcome research	118
Blood pressure adaptation in vertebrates: comparative biology	116
A case of ANCA-associated vasculitis after AZD1222 (Oxford–AstraZeneca) SARS-CoV-2 vaccination: casualty or causality?	113
Improving frozen section evaluation of procurement donor kidney biopsies and reducing the discard rate: a promising role for artificial intelligence	111
Proximal-tubule molecular relay from early Protein diaphanous homolog 1 to late Rho-associated protein kinase 1 regulates kidney function in obesity-induced kidney damage	104
Including APOL1 alleles and ancestry adjustments improve a genome-wide polygenic CKD score	103
Identification of the gut microbial enzyme turning the urine yellow	99
Epigenetic alterations and memory: key players in the development/progression of chronic kidney disease promoted by acute kidney injury and diabetes	97

Dysfunction of the circadian clock in the kidney tubule leads to enhanced kidney gluconeogenesis and exacerbated hyperglycemia in diabetes	94
Unlocking the full potential of human pluripotent stem cell–derived kidney organoids through bioengineering	88
Monoclonal immunoglobulin crystalline nephropathies	83
New advances in endocrine hypertension: from genes to biomarkers	82
Enhancing kidney organoid maturity with inducible vascularization: another step forward for in vitro modeling	79
Kidney protective mechanisms of SGLT2 inhibitors: evidence for a hemodynamic effect	79
Caloric restriction reduces the pro-inflammatory eicosanoid 20-hydroxyeicosatetraenoic acid to protect from acute kidney injury	77
Unexpected metabolic effects of sodium-glucose cotransporter 2 inhibitors	77
Neutrophil gelatinase-associated lipocalin is elevated in children with acute kidney injury and sickle cell anemia, and predicts mortality	77
Seeing through the density of dense deposit disease	76
Glomerular-tubular crosstalk via cold shock Y-box binding protein-1 in the kidney	76
Should we consider calcimimetics as a therapeutic option for nephrotic syndrome?	75
Ttc21b deficiency attenuates autosomal dominant polycystic kidney disease in a kidney tubular- and maturation-dependent manner	74
Rationale and design of the Nephrotic Syndrome Study Network (NEPTUNE) Match in glomerular diseases: designing the right trial for the right patient, today	73
Multi-omics and imaging mass cytometry characterization of human kidneys to identify pathways and phenotypes associated with impaired kidney function	73
Women and kidney health: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference	70
On the relevance of thrombomodulin variants in atypical hemolytic uremic syndrome	70
A single approach to targeting transferrin receptor 2 corrects iron and erythropoietic defects in murine models of anemia of inflammation and chronic kidney disease	70
Trans-ethnic genome-wide association study of blood metabolites in the Chronic Renal Insufficiency Cohort (CRIC) study	69
Antibody and T-cell response to a third dose of SARS-CoV-2 mRNA BNT162b2 vaccine in kidney transplant recipients	68
Kidney supportive care: every nephrologist’s business	68
Editorial Board	67
The authors reply	67
Cinacalcet in focal segmental glomerular sclerosis: a case report	66
Response to the commentary “Modeling pulse wave velocity trajectories—challenges, opportunities, and pitfalls”	64
Editorial Board	63
Subscription Information	63
In This Issue	63
Unexpected cause of vemurafenib-induced nephrotoxicity: ferrochelatase	62
in this issue	62
Mutations in tumor suppressor genes Vhl and Rassf1a cause DNA damage, chromosomal instability and induce gene expression changes characteristic of clear cell renal cell carcinoma	62
Editorial Board	62
First do no harm: systemic glucocorticoids should not be used for the treatment of progressive IgA nephropathy	61
A genomic deep field view of hypertension	60
Immunoaging within the kidney via injury-associated tertiary lymphoid tissue	60
The Case | A patient with autosomal dominant polycystic kidney disease with an atypical kidney magnetic resonance image	60
Urine: from waste to fertilizer	59
The authors reply	59
Letter to the Editor	58
RORing toward immunoregulation in glomerulonephritis?	58
The T-cell environment: may the regulatory force be with you	56
Improving the management of chronic kidney disease in primary care by enhancing laboratory reports with additional information and follow-up procedures	55
The changing epidemiology of acute kidney injury syndromes in the face of emerging respiratory viral pandemic illnesses	55
Kidney traits on repeat—the role of MUC1 VNTR	54
Erratum to Kudose S, Lipton M, Jain NG, D’Agati VD. “Valproic acid–associated proximal tubulopathy.” Kidney Int. 2022;101:653	53
The Case | A patient with skin rash, monoclonal gammopathy, and proteinuria	53
Erdheim-Chester disease: hairy kidney and coated aorta	53
Subscription Information	53
journal club	52
Renal artery microaneurysms in antineutrophil cytoplasmic antibody–associated vasculitis	52

Acknowledgment of reviewers	51
The transcription factor ATF4 mediates endoplasmic reticulum stress-related podocyte injury and slit diaphragm defects	50
The Case | Is this hemolytic uremic syndrome?	50
Tumor-induced osteomalacia	50
Repression of peroxisome proliferation-activated receptor γ coactivator-1α by p53 after kidney injury promotes mitochondrial damage and maladaptive kidney repair	49
Crystal-induced colitis	49
The Case | Neonatal seizures and tubular dysfunction in childhood: joining the dots!	49
Impact of study design on vaccine effectiveness estimates of 2 mRNA COVID-19 vaccine doses in patients with stage 5 chronic kidney disease	49
Identifying strategies for disseminating research to patients with chronic kidney disease and caregivers: a workshop report	48
Pathological findings of immunotherapy-induced nephrotoxicity in a humanized immune system mouse model	48
Expanding the perspective: addressing additional limitations in cardiovascular risk assessment of immunosuppressive therapies	47
Kidney transplantation and hyperbaric oxygen treatment for calciphylaxis	47
Corrigendum to “Effects of dialysate potassium concentration of 3.0 mmol/l with sodium zirconium cyclosilicate on dialysis-free days versus dialysate potassium concentration of 2.0 mmol/l alone on rat	47
Mitochondrial ROS connects P2X7-mediated Ca2+ influx with IL-1α release by monocytes upon chronic tissue damage	47
Corrigendum to “Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Management of ANCA–Associated Vasculitis.” Kidney International 2024;105(3):447–449	46
To do or not to do—genetic testing for autosomal dominant polycystic kidney disease in children and adolescents	46
Age and memory B cells at baseline are associated with risk of relapse and memory B-cell reappearance following anti-CD20 treatment in pediatric frequently-relapsing/steroid-dependent nephrotic syndro	46
Renal Pathology Society/International Kidney and Monoclonal Gammopathy Research Group consensus on pathologic definitions and terminology of monoclonal gammopathy–associated kidney lesions	45
Machine learning does not outperform traditional statistical modelling for kidney allograft failure prediction	45
Protein kinase ROCK1 activates mitochondrial fission linking to oxidative stress and muscle atrophy	45
Complement activation and effector pathways in membranous nephropathy	45
The prevention and management of chronic kidney disease among patients with metabolic syndrome	45
Dynamically visualizing profibrotic maladaptive repair after acute kidney injury by fibroblast activation protein imaging	44
Hypoxia hits APOL1 in the kidney	44
Discrepancies between transcutaneous and estimated glomerular filtration rates in rats	44
The randomized DIALIZE-Outcomes trial evaluated sodium zirconium cyclosilicate in hemodialysis	44
Deciphering missense coding variants with AlphaMissense	43
Expression of concern from the KI Editors: “Apolipoprotein-1 risk variants and associated kidney phenotypes in an adult HIV cohort in Nigeria” [Kidney International, July 2021, Pages 146–154] and “APO	43
The relationship between imaging features of diffusion-weighted imaging and prognosis of chronic kidney disease	43
Title Page	43
Editorial Board	43
The authors reply	43
Findings from 4C-T Study demonstrate an increased cardiovascular burden in girls with end stage kidney disease and kidney transplantation	43
Table of Contents	42
Initiation of maintenance dialysis: back to the future	42
Editorial Board	41
Subscription Information	41
in this issue	41
Estimating glomerular filtration rate from serum creatinine concentration in children with augmented renal clearance: all formulas are equivocal, but some are more equivocal than others	40
A pragmatic, open-label, randomized controlled trial of Plasma-Lyte-148 versus standard intravenous fluids in children receiving kidney transplants (PLUTO)	40
Table of Contents	40
Subscription Information	40
Good and evil, more reasons to study UPR	40
Integrating basic science with translational research: the 13th International Podocyte Conference 2021	40
Subscription Information	39
Do macrophages inhibit or promote atheroma plaque calcification and stability?	39
The Case | Acute kidney injury and a facial lesion	39
Modeling pulse wave velocity trajectories—challenges, opportunities, and pitfalls	38
Kidney biopsy in acute kidney injury: increase insight or preserve the status quo?	38
Table of Contents	38
Enhancer and super-enhancer landscape in polycystic kidney disease	37
Advancing proteomics in nephrology: unraveling causal pathways and therapeutic targets	37
The lupus nephritis management renaissance	37
Dried blood spot testing versus standard i.v. sampling for GFR measurement with iohexol or 99mTc-DTPA	37
Podocyte protease activated receptor 1 stimulation in mice produces focal segmental glomerulosclerosis mirroring human disease signaling events	36
Role of proteinuria in the anemia of chronic kidney disease	36
Effective management of chyluria with retrograde thoracic duct catheterization and embolization	36
Endemic rise in cases of acute kidney injury in children in Indonesia and Gambia: what is the likely culprit and why?	36
Humoral response after 3 doses of the BNT162b2 mRNA COVID-19 vaccine in patients on hemodialysis	35
Apixaban for stroke prevention in hemodialysis patients with nonvalvular atrial fibrillation	35
Molecular profiling of kidney compartments from serial biopsies differentiate treatment responders from non-responders in lupus nephritis	35
Anti-nephrin autoantibodies: novel predictors of post-transplant recurrence of focal segmental glomerular sclerosis	35
The authors reply:	35
Risk stratification of metabolic disorder–associated kidney disease	35
New-onset class III lupus nephritis with multi-organ involvement after COVID-19 vaccination	35
Editorial Board	35
Critical Role of histone deacetylase 3 in the regulation of kidney inflammation and fibrosis	35
Female sex hormones inversely regulate acute kidney disease susceptibility throughout life	35
Cardiovascular disease as a risk factor for frailty in dialysis patients	34
Insulin-like growth factor binding protein 7 promotes acute kidney injury by alleviating poly ADP ribose polymerase 1 degradation	34
A paired-kidney allocation study found superior survival with HLA-DR compatible kidney transplants in the Eurotransplant Senior Program	34
Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease: known knowns and known unknowns	34
Loss of proximal tubular transcription factor Krüppel-like factor 15 exacerbates kidney injury through loss of fatty acid oxidation	34
High-dimensional mass cytometry identified circulating natural killer T-cell subsets associated with protection from cytomegalovirus infection in kidney transplant recipients	34
Contactin-1–associated membranous nephropathy: complete immunologic and clinical remission with rituximab	34
Phosphoenolpyruvate carboxykinase 1-mediated cataplerosis is required to maintain mitochondrial fitness and to avoid kidney disease progression	34
Acute kidney injury with gross hematuria and IgA nephropathy after COVID-19 vaccination	34
Lineage tracing analysis defines erythropoietin-producing cells as a distinct subpopulation of resident fibroblasts with unique behaviors	34
The nucleotide-sensing Toll-Like Receptor 9/Toll-Like Receptor 7 system is a potential therapeutic target for IgA nephropathy	33
The authors reply	33

National and international kidney failure registries: characteristics, commonalities, and contrasts	33
ER stress and slit diaphragms: is there a connection?	33
Subscription Information	32
A novel model of nephrotic syndrome results from a point mutation in Lama5 and is modified by genetic background	32
in this issue	32
journal club	32
Subscription Information	32
Uremia-associated fibrinous pericarditis	32
Acquired cutis laxa from heavy chain deposition disease	32
Editorial Board	32
Protective mechanisms harnessing against injurious heme and preventing kidney damage in STEC-HUS: toward new therapies?	32
Is bone histomorphometry required for assessment of renal osteodystrophy in clinical practice?	32
Executive summary of the KDIGO 2025 Clinical Practice Guideline for the Management of Nephrotic Syndrome in Children	30
Recommendations from the EXTRIP workgroup on extracorporeal treatment for baclofen poisoning	30
Has APOL1 kidney disease treatment been hiding in plain sight?	30
Glomerular filtration rate estimation in transgender and gender-diverse adults using gender-affirming hormone therapy: an exploratory cross-sectional study	30
Development of an international Delphi survey to establish core outcome domains for trials in adults with glomerular disease	30
Subscription Information	30
Kidney targeting of formoterol containing polymeric nanoparticles improves recovery from ischemia reperfusion-induced acute kidney injury in mice	30
In this Issue	30
The author replies:	30
A multiomic resource to interpret genetic associations with kidney function	29
Mendelian randomization for nephrologists	29
The Case | Dark dialysate after colonoscopy	28
Using prediction models to improve care and communicate risk: updated modeling for children with IgA nephropathy	28
Reevaluating principal component analysis: advocating for nonlinear and nonparametric methods in multi-omics data analysis	28
Antioxidant nanozymes for prevention of diseased kidney from failure	28
Table of Contents	28
How cyclosporine reduces mycophenolic acid exposure by 40% while other calcineurin inhibitors do not	28
Differing sensitivities to angiotensin converting enzyme inhibition of kidney disease mediated by APOL1 high-risk variants G1 and G2	28
The authors reply:	28
Non-canonical Wnt/calcium signaling is protective against podocyte injury and glomerulosclerosis	28
Are your kidneys Ok? Detect early to protect kidney health	28
Kidney toxicity of phosphate: is that crystal clear yet?	27
The Case | An unusual cause of proteinuria in a kidney transplant recipient	27
Asymptomatic migration of a peritoneal dialysis catheter	27
The authors reply	27
Progress, challenges, and pragmatic concessions in predicting relative risk of kidney survival in ARPKD	27
An introduction to realist evaluation and synthesis for kidney research	27
The authors reply	27
A national registry study evaluated the landscape of kidney transplantation among presumed unauthorized immigrants in the United States	26
A polygenic score for reduced kidney function and adverse outcomes in a cohort with chronic kidney disease	26
Valproic acid–associated proximal tubulopathy	26
in this issue	26
Series introduction: drug repurposing for kidney diseases	26
In remembrance of Gary Striker, MD (1934–2024)	26
Anti-nephrin antibodies guide living donor kidney transplantation in a pediatric patient with primary focal segmental glomerular sclerosis	26
Scaffold polarity proteins Par3A and Par3B share redundant functions while Par3B acts independent of atypical protein kinase C/Par6 in podocytes to maintain the kidney filtration barrier	26
Receptor activator of NF-κB mediates podocyte injury in diabetic nephropathy	25
Should vaccination against COVID-19 be mandated in patients on the transplant waiting list?	25
Neutralizing antibody response against variants of concern after vaccination of dialysis patients with BNT162b2	25
A genetically inducible endothelial niche enables vascularization of human kidney organoids with multilineage maturation and emergence of renin expressing cells	25
KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD): executive summary	25
Editorial Board	25
Autogenous brachial-axillary translocated superficial femoral vein hemodialysis access with a prosthetic outflow bypass	25
Subscription Information	25
The inflammatory state is a risk factor for cardiovascular disease and graft fibrosis in kidney transplantation	25
Conservative kidney management and kidney supportive care: core components of integrated care for people with kidney failure	25
Myeloid-derived growth factor deficiency exacerbates mitotic catastrophe of podocytes in glomerular disease	25
Journal club	25
Subscription Information	25
Precision nephrology identified tumor necrosis factor activation variability in minimal change disease and focal segmental glomerulosclerosis	25
In this issue	25
Preventing MMP23-mediated cleavage of podocyte RARRES1: a novel strategy to halt chronic kidney disease progression?	24
Corrigendum to Cai J, Liu Z, Huang X, et al. The deacetylase sirtuin 6 protects against kidney fibrosis by epigenetically blocking β-catenin target gene expression Kidney Int. 2020;97:106–118	24
IL-22 is secreted by proximal tubule cells and regulates DNA damage response and cell death in acute kidney injury	24
Myeloperoxidase-ANCA IgG induces different forms of small vessel vasculitis based on type of synergistic immune stimuli	24
In memoriam: George L. Bakris, MD, 1952–2024	24
in this issue	24
Targeting angiopoietin-2 as a novel treatment option for kidney fibrosis	24
Advanced optical imaging reveals preferred spatial orientation of podocyte processes along the axis of glomerular capillaries	24
Cilastatin, a new therapeutic promise for acute kidney injury	24
Title Page	24
Unique problems for the design of the first trials of transplanting porcine kidneys into humans	24
Population-based reference values for kidney function and kidney function decline in 25- to 95-year-old Germans without and with diabetes	24
E-prostanoid 3 receptor deficiency on myeloid cells protects against ischemic acute kidney injury via breaking the auto-amplification loop of necroinflammation	23
Table of Contents	23
Breakthrough omicron COVID-19 infections in patients receiving the REGEN-Cov antibody combination	23
Suppression of aldehyde dehydrogenase 2 in kidney proximal tubules contributes to kidney fibrosis through Transforming Growth Factor-β signaling	23
Paraspeckle protein NONO attenuates vascular calcification by inhibiting bone morphogenetic protein 2 transcription	23
Post hoc analysis of SUSTAIN 6 and PIONEER 6 trials suggests that people with type 2 diabetes at high cardiovascular risk treated with semaglutide experience more stable kidney function compared with	23
A multiple 24-hour urine collection study indicates that kidney function decline is related to urinary sodium and potassium excretion in patients with chronic kidney disease	23
in this issue	23
Type I interferon–related kidney disorders	23
The Mayo MGRS Prediction Tool calculates the risk of finding monoclonal gammopathy of renal significance in a kidney biopsy in patients with monoclonal gammopathy	23
Phospholipase A2receptor-positive membranous nephropathy detected by laser microdissection and mass spectrometry in patients negative by immunofluorescence for phospholipase A2receptor on kidney biops	23
Hemolysis is associated with altered heparan sulfate of the endothelial glycocalyx and with local complement activation in thrombotic microangiopathies	23
Renal AA amyloidosis: presentation, diagnosis, and current therapeutic options: a review	23
The CCR6/CCL20 axis expands RORγt+ Tregs to protect from glomerulonephritis	23
Multi-stain deep learning prediction model of treatment response in lupus nephritis based on renal histopathology	23
A Mendelian randomization study found causal linkage between telomere attrition and chronic kidney disease	22
Results of the EPISODE trial plead for reasonable practice-based serum phosphate lowering in patients on dialysis	22
A reliable clinical test for detection of membranous nephropathy antigens using laser microdissection and mass spectrometry	22
Insights from ADPedKD, ERKReg and RaDaR registries provide a multi-national perspective on the presentation of childhood autosomal dominant polycystic kidney disease in high- and middle-income countri	22
Bile cast nephropathy after sinusoidal obstruction syndrome	22